Table 2.
Item | Group I * | Group II * | Group III * | Group IV * | Group V * | Group VI * |
---|---|---|---|---|---|---|
Area percentage of TNF-α | 14.301 ± 3.590 b,c,d |
48.562 ± 5.654 a,c,d,e,f | 36.804 ± 2.674 a,b,d,e,f |
19.008 ± 2.102 a,b,c,e,f |
16.741 ± 1.755 b,c,d |
15.141± 2.097 b,c,d |
The color intensity of TNF-α | 10.468 ± 1.746 b,c,d |
56.555 ± 4.648 a,c,d,e,f | 49.781 ± 2.667 a,b,d,e,f |
13.634 ± 2.172 a,b,c,f |
12.491 ± 3.164 b,c |
10.077 ± 1.548 b,c,d |
Area percentage of COX-2 | 14.468 ± 1.744 b,c,d |
48.885 ± 4.942 a,c,d,e,f |
35.416 ± 2.972 a,b,d,e,f |
17.931 ± 2.49 a,b,c |
16.611 ± 2.27 b,c |
15.618 ± 1.959 b,c |
The color intensity of COX-2 | 11.623 ± 1.873 b,c,d |
46.024 ± 9.21 a, d,e,f |
44.313 ± 8.778 a,d,e,f |
14.315 ± 1.568 a,b,c,e,f |
12.007 ± 2.172 b,c,d |
11.777 ± 1.726 b,c,d |
Area percentage of NF-κb | 10.102 ± 1.359 b,c,d |
35.093 ± 2.94 a,c,d,e,f |
26.957 ± 4.768 a,b,d,e,f |
11.879 ± 0.905 a,b,c,f |
11.770 ± 1.137 b,c |
9.797 ± 2.204 b,c,d |
The color intensity of NF-κb | 15.016 ± 3.119 b,c,d |
57.511 ± 6.423 a,c,d,e,f |
43.3 ± 2.281 a,b,d,e,f |
20.808 ± 5.3 a,b,c,f |
17.722 ± 3.62 b,c |
15.764 ± 3.459 b,c,d |
Area percentage of Bcl-2 | 48.329 ± 4.509 b,c,d |
15.460 ± 3.666 a,d,e,f |
21.161 ± 4.128 a,b,d,e,f | 42.01 ± 4.137 a,b,c,f |
45.047 ± 3.435 b,c |
45.933 ± 3.992 b,c,d |
The color intensity of Bcl-2 | 46.524 ± 3.213 b,c,d |
17.404 ± 4.283 a,d,e,f |
25.372 ± 3.233 a,b,d,e,f |
42.52 ± 2.448 a,b,c,f |
44.091 ± 3.846 b,c |
45.465 ± 3.395 b,c,d |
* Data are displayed as mean ± SD of the studied group. The letter a denotes significance compared to group I (control); b denotes significance in comparison with group II (diseased); c denotes significance in comparison with group III (diseased, 50 mg/kg FEE); d denotes significance in comparison with group IV (diseased, 100 mg/kg FEE); e denotes significance in comparison with group V (diseased, 150 mg/kg FEE); and f denotes significance in comparison with group VI (150 mg/kg FEE only).